Clínic Barcelona

An artificial intelligence tool has been developed to predict the evolution of patients with multiple sclerosis

  • This study is an international collaboration coordinated by the Hospital del Mar Research Institute and the Hospital Clínic-IDIBAPS and published in the Journal of Neurology
  • This new tool may allow the follow-up and treatment of patients to be adapted to their future evolution, opting for the most effective approaches, but also with more possible side effects in those with a poorer prognosis
  • The exact factors behind the progression of disability in multiple sclerosis—a highly heterogeneous disease—are unknown, which is why it is so important to have tools of this type
Sara Llufriu from Clínic-IDIBAPS

Sara Llufriu from Clínic-IDIBAPS

Related contents
Keep reading about: